Does age affect outcome with breast cancer? by Emily B Jackson, Lovedeep Gondara, Caroline Speers, Rekha Diocee, Alan M Nichol, Caroline Lohrisch, Karen A Gelmon

Get full text

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

Get full text

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Canc... by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

Get full text

Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape by Emily B. Jackson, Lauren Curry, Caroline Mariano, Tina Hsu, Sarah Cook, Rossanna C. Pezo, Marie-France Savard, Danielle N. Desautels, Dominique Leblanc, Karen A. Gelmon

Get full text

Improving Care for Older Adults with Cancer in Canada: A Call to Action by Sarah Cook, Shabbir Alibhai, Rajin Mehta, Marie-France Savard, Caroline Mariano, Dominique LeBlanc, Danielle Desautels, Rossanna Pezo, Xiaofu Zhu, Karen A. Gelmon, Tina Hsu

Get full text

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer by Jeffrey Q. Cao, Brae Surgeoner, Mita Manna, Jean-François Boileau, Karen A. Gelmon, Muriel Brackstone, Christine Brezden-Masley, Katarzyna J. Jerzak, Ipshita Prakash, Sandeep Sehdev, Stephanie M. Wong, Nathaniel Bouganim, David W. Cescon, Stephen Chia, Ian S. Dayes, Anil Abraham Joy, Jan-Willem Henning

Get full text

Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib by Zhou Zhu, Nicholas C. Turner, Sherene Loi, Fabrice André, Miguel Martin, Véronique Diéras, Karen A. Gelmon, Nadia Harbeck, Cathy Zhang, Joan Q. Cao, Zhengming Yan, Dongrui R. Lu, Ping Wei, Todd L. VanArsdale, Paul A. Rejto, Xin Huang, Hope S. Rugo, Sibylle Loibl, Massimo Cristofanilli, Richard S. Finn, Yuan Liu

Get full text

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Se... by Mita Manna, Karen A. Gelmon, Jean-François Boileau, Christine Brezden-Masley, Jeffrey Q. Cao, Katarzyna J. Jerzak, Ipshita Prakash, Sandeep Sehdev, Christine Simmons, Nathaniel Bouganim, Muriel Brackstone, David W. Cescon, Stephen Chia, Ian S. Dayes, Scott Edwards, John Hilton, Anil Abraham Joy, Kara Laing, Marc Webster, Jan-Willem Henning

Get full text

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial by Katya Galactionova, Sibylle Loibl, Paola Salari, Frederik Marmé, Miguel Martin, Miguel Martin, Michael Untch, Hervé R. Bonnefoi, Sung-Bae Kim, Harry D. Bear, Nicole McCarthy, Nicole McCarthy, Karen A. Gelmon, José A. García-Sáenz, José A. García-Sáenz, Catherine M. Kelly, Toralf Reimer, Masakazu Toi, Hope S. Rugo, Michael Gnant, Andreas Makris, Nicole Burchardi, Matthias Schwenkglenks

Get full text

Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial by Pamela J. Goodwin, Ryan J. O. Dowling, Marguerite Ennis, Bingshu E. Chen, Wendy R. Parulekar, Lois E. Shepherd, Margot J. Burnell, Rachel Vander Meer, Andrea Molckovsky, Anagha Gurjal, Karen A. Gelmon, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Whelan, Timothy J. Hobday, Priya Rastogi, Manuela Rabaglio-Poretti, Julie Lemieux, Alastair M. Thompson, Daniel W. Rea, Vuk Stambolic

Get full text